BridgeMD
New treatment option for Macular Diseases
Official title Acute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL
ClinicalTrials.gov ID: NCT06893965
What this study is testing
- What it's testing
- In just a few years, intravitreal injections have become a standard method of administration for certain retinal deseases (age-related macular degeneration [AMD], diabetic edematous maculopathy or retinal vein occlusion [RVO]). Thus, vascular endothelial growth factor (anti-VEGF) inhibitors are injected repetitively, every 4 to 6 weeks, in some patients in order to treat such pathologies.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient aged 18 or over;
- Patient with an indication for Aflibercept 8mg/0.07mL (EYLEA 8mg)
- Naive or switched patient, i.e. so-called suboptimal responder to anti-VEGF with high injection frequencies
- Patient with rights to social security
- Having given free and informed consent before any participation in research.
You likely can't join if
- Pregnant or breastfeeding woman
- Patient under legal protection (guardianship, curatorship, etc.) or legal protection
- Patient with significant astigmatism distorting the IOP values in applanation
- Any other reason that, in the opinion of the investigator, could interfere with the evaluation of the study objectives
The study team makes the final eligibility decision.
Where it's taking place
- Toulon, Var, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toulon, Var, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.